Literature DB >> 8291607

Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau.

V Askanas1, W K Engel, M Bilak, R B Alvarez, D J Selkoe.   

Abstract

We immunostained muscle biopsies of 8 patients with sporadic inclusion body myositis (S-IBM), 7 patients with autosomal recessive hereditary inclusion body myopathy (H-IBM) (both diseases being characterized by similar muscle fiber vacuoles containing inclusions), and 11 normal and disease controls. We used the following well-characterized antibodies against tau protein: Tau-1, Alz-50, and anti-paired helical filament (PHF) antiserum. By light microscopy, in all S-IBM muscle biopsies virtually all vacuoles immunoreactive for ubiquitin and beta-amyloid protein also contained inclusions immunoreactive with Alz-50 and anti-PHF antiserum. With tau-1 antibody, strong immunoreactivity in the vacuoles was obtained only after dephosphorylation of muscle sections. By electronmicroscopy, all three antibodies immunodecorated exclusively cytoplasmic twisted tubulofilaments (TTFs). In H-IBM, virtually all ubiquitin and beta-amyloid-positive muscle fiber vacuoles contained inclusions immunoreactive with anti-PHF antiserum, but in only 40% of those fibers were the inclusions immunoreactive with Alz-50. In six H-IBM patients there were no tau-1 immunoreactive inclusions in any of their vacuolated muscle fibers; in one patient, 24% of the vacuolated fibers had tau-1 immunoreactivity. By demonstrating that hyperphosphorylated tau, which is characteristic of Alzheimer brain PHFs, is a component of S-IBM-muscle TTFs (which are also ultrastructurally similar to PHFs), our study: 1) provides the first demonstration of abnormally accumulated tau in nonneural tissue and 2) suggests that the cytopathogenesis in Alzheimer brain and S-IBM muscle may share some similar mechanisms. Whether the difference in tau immunoreactivity between S-IBM and most of the H-IBM patients reflects a difference in genetically determined transcriptional or posttranslational modifications of tau protein or other factors remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8291607      PMCID: PMC1887131     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Ubiquitin is a component of paired helical filaments in Alzheimer's disease.

Authors:  H Mori; J Kondo; Y Ihara
Journal:  Science       Date:  1987-03-27       Impact factor: 47.728

2.  A neuronal antigen in the brains of Alzheimer patients.

Authors:  B L Wolozin; A Pruchnicki; D W Dickson; P Davies
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

3.  Quantitation and immunocytochemical localization of ubiquitin conjugates within rat red and white skeletal muscles.

Authors:  D A Riley; J L Bain; S Ellis; A L Haas
Journal:  J Histochem Cytochem       Date:  1988-06       Impact factor: 2.479

4.  Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.

Authors:  G Perry; R Friedman; G Shaw; V Chau
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 5.  Molecular characterization of microtubule-associated proteins tau and MAP2.

Authors:  M Goedert; R A Crowther; C C Garner
Journal:  Trends Neurosci       Date:  1991-05       Impact factor: 13.837

6.  Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. A new syndrome.

Authors:  A J Cole; R Kuzniecky; G Karpati; S Carpenter; E Andermann; F Andermann
Journal:  Brain       Date:  1988-10       Impact factor: 13.501

7.  Inclusion body myositis. Observations in 40 patients.

Authors:  B P Lotz; A G Engel; H Nishino; J C Stevens; W J Litchy
Journal:  Brain       Date:  1989-06       Impact factor: 13.501

8.  The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition.

Authors:  M Tabaton; T I Mandybur; G Perry; M Onorato; L Autilio-Gambetti; P Gambetti
Journal:  Ann Neurol       Date:  1989-12       Impact factor: 10.422

9.  The monoclonal antibody, Alz 50, recognizes tau proteins in Alzheimer's disease brain.

Authors:  N Nukina; K S Kosik; D J Selkoe
Journal:  Neurosci Lett       Date:  1988-05-03       Impact factor: 3.046

10.  Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease.

Authors:  N W Kowall; K S Kosik
Journal:  Ann Neurol       Date:  1987-11       Impact factor: 10.422

View more
  38 in total

1.  Paired helical filaments of inclusion-body myositis muscle contain RNA and survival motor neuron protein.

Authors:  A Broccolini; W K Engel; R B Alvarez; V Askanas
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice.

Authors:  V Askanas; W K Engel
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

3.  Glucocorticoid-sensitive hereditary inclusion body myositis.

Authors:  M Naumann; H Reichmann; H H Goebel; C Moll; K V Toyka
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

4.  Immunohistochemical and ultrastructural analysis of sporadic inclusion body myositis: a case series.

Authors:  Katarzyna Haczkiewicz; Agata Sebastian; Aleksandra Piotrowska; Maria Misterska-Skóra; Agnieszka Hałoń; Marta Skoczyńska; Maciej Sebastian; Piotr Wiland; Piotr Dzięgiel; Marzenna Podhorska-Okołów
Journal:  Rheumatol Int       Date:  2018-12-08       Impact factor: 2.631

5.  Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation.

Authors:  G M Wilczynski; W K Engel; V Askanas
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

6.  Formation of gelsolin amyloid fibrils in the rough endoplasmic reticulum of skeletal muscle in the gelsolin mouse model of inclusion body myositis: comparative analysis to human sporadic inclusion body myositis.

Authors:  Sergei I Bannykh; William E Balch; Jeffery W Kelly; Lesley J Page; G Diane Shelton
Journal:  Ultrastruct Pathol       Date:  2013-10       Impact factor: 1.094

7.  Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes.

Authors:  Judith Miklossy; Hong Qing; Aleksandra Radenovic; Andras Kis; Bertrand Vileno; Forró Làszló; Lisa Miller; Ralph N Martins; Gerard Waeber; Vincent Mooser; Fred Bosman; Kamel Khalili; Nune Darbinian; Patrick L McGeer
Journal:  Neurobiol Aging       Date:  2008-10-23       Impact factor: 4.673

8.  Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.

Authors:  L W Jin; M G Hearn; C E Ogburn; N Dang; D Nochlin; W C Ladiges; G M Martin
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

9.  Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.

Authors:  K Fukuchi; D Pham; M Hart; L Li; J R Lindsey
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

10.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.